Key Takeaways
- Shares closed at HK$41.86, a 108.3% increase from the HK$20.10 IPO price.
- The stock opened at HK$35.5 and traded as high as HK$45.8 during the session.
- Total turnover reached HK$544.22 million on a volume of 15.13 million shares.
Back
Impact Therap-B stock soars 108.3% on Hong Kong debut
IMPACT THERAP-B (07630.HK) surged 108.3% in its Hong Kong trading debut, closing at HK$41.86 after a strong open.
The stock opened at HK$35.5, 76.6% above its initial public offering price of HK$20.10, according to exchange data.
Throughout the day, shares of the biotechnology firm reached a high of HK$45.8 and a low of HK$33.1. The session saw significant investor interest, with 15.13 million shares changing hands, resulting in a total turnover of HK$544.22 million.
For investors who participated in the IPO, the first-day pop translated to a paper gain of HK$4,352 per 200-share board lot, excluding handling fees.
The successful listing demonstrates continued investor appetite for biotechnology firms on the Hong Kong exchange. The stock's performance in the coming weeks will be a key test of whether the initial enthusiasm can be sustained beyond the IPO flip.
This article is for informational purposes only and does not constitute investment advice.
